Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

5.94
Delayed Data
As of Feb 05
 -0.41 / -6.46%
Today’s Change
5.23
Today|||52-Week Range
21.22
-31.88%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close6.35
Today’s open6.33
Day’s range5.83 - 6.81
Volume691,896
Average volume (3 months)491,995
Market cap$310.9M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+7.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book2.20

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...-0.11-2.32%
CNCEConcert Pharmaceutic...-0.48-3.27%
ADMSAdamas Pharmaceutica...-1.14-6.96%
CMRXChimerix Inc-0.37-5.07%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
Chief Operating, Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts

Partner Offers